Evidence map›Paper›PMID 29343685›Full record

ArticleNature communications2018

The protective role of DOT1L in UV-induced melanomagenesis.

Bo Zhu, Shuyang Chen, Hongshen Wang, Chengqian Yin, Changpeng Han, Cong Peng, Zhaoqian Liu, Lixin Wan, Xiaoyang Zhang, Jie Zhang and 20 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. DNA Repair in Nucleosomes: Insights from Histone Modifications and Mutants.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Epigenetic Regulation of Nucleotide Excision Repair.Frontiers in cell and developmental biology · 2022
    Review
  19. Signal pathways of melanoma and targeted therapy.Signal transduction and targeted therapy · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 18 institutions in 5 countries.

Bo ZhuDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, 02118, USA.
Shuyang ChenDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, 02118, USA.
Hongshen WangDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, 02118, USA.
Chengqian YinDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, 02118, USA.ORCID http://orcid.org/0000-0003-4247-6245
Changpeng HanDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, 02118, USA.
Cong PengDepartment of Dermatology & China Hunan key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, 410008, Changsha, China.
Zhaoqian LiuDepartment of Dermatology & China Hunan key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, 410008, Changsha, China.
Lixin WanDepartment of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.
Xiaoyang ZhangDana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
Jie ZhangDepartment of Computer Science, New Jersey Institute of Technology, Newark, NJ, 07102, USA.ORCID http://orcid.org/0000-0003-0242-8812
Christine G LianDepartment of Pathology, The Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Ave, Boston, MA, 02115, USA.
Peilin MaDepartment of Pathology, Indiana University School of Medicine, 340 West 10th Street, Fairbanks 6200, Indianapolis, IN, 46202, USA.
Zhi-Xiang XuDivision of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, AL, 35233, USA.
Sharon PrinceDepartment of Human Biology, University of Cape Town, Rondebosch, Cape Town, 7700, South Africa.
Tao WangTianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 300193, Tianjin, China.
Xiumei GaoTianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 300193, Tianjin, China.
Yujiang ShiDepartment of Medicine, Endocrinology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.
Dali LiuDepartment of Chemistry and Biochemistry, Loyola University Chicago, Chicago, IL, 60660, USA.
Min LiuShandong Provincial Key Laboratory of Animal Resistance Biology, Institute of Biomedical Sciences, College of Life Sciences, Shandong Normal University, 250014, Jinan, China.
Wenyi WeiDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0003-0512-3811
Zhi WeiDepartment of Computer Science, New Jersey Institute of Technology, Newark, NJ, 07102, USA.
Jingxuan PanCancer Pharmacology Research Institute, Jinan University, 510632, Guangzhou, China.
Yongjun WangShanghai University of Traditional Chinese Medicine, 201203, Shanghai, China.
Zhenyu XuanDepartment of Biological Sciences, Center for Systems Biology, University of Texas at Dallas, Richardson, TX, 75080, USA.
Jay HessDepartment of Pathology, Indiana University School of Medicine, 340 West 10th Street, Fairbanks 6200, Indianapolis, IN, 46202, USA.
Nicholas K HaywardQIMR Berghofer Medical Research Institute, Brisbane City, QLD, 4006, Australia.
Colin R GodingLudwig Institute for Cancer Research, University of Oxford, Headington, Oxford, OX3 7DQ, UK.
Xiang ChenDepartment of Dermatology & China Hunan key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, 410008, Changsha, China. chenxiangck@126.com.
Jun ZhouShandong Provincial Key Laboratory of Animal Resistance Biology, Institute of Biomedical Sciences, College of Life Sciences, Shandong Normal University, 250014, Jinan, China. junzhou@sdnu.edu.cn.
Rutao CuiDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, 02118, USA. rutaocui@bu.edu.
Boston University · USCentral South University · CNBrigham and Women's Hospital · USIndiana University School of MedicineNew Jersey Institute of Technology · USShandong Normal University · CNTianjin University of Traditional Chinese Medicine · CNBeth Israel Deaconess Medical Center · USDana-Farber Cancer Institute · USJinan University · CNLoyola University Chicago · USMoffitt Cancer Center · USQIMR Berghofer Medical Research Institute · AUShanghai University of Traditional Chinese Medicine · CNThe University of Texas at Dallas · USUniversity of Alabama at Birmingham · USUniversity of Cape Town · ZAUniversity of Oxford · GB

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Tumor Assessment CoreP01CA128814 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI SMITH, JEFFREY W · 2009 to 2020
$19.1M
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia TreatmentR00CA183914 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI WAN, LIXIN · 2016 to 2018
$652k
NCATS NIH HHS UL1 TR001430NCI NIH HHS P01 CA128814NCI NIH HHS R00 CA183914
6 · The paper itself

Abstract

The DOT1L histone H3 lysine 79 (H3K79) methyltransferase plays an oncogenic role in MLL-rearranged leukemogenesis. Here, we demonstrate that, in contrast to MLL-rearranged leukemia, DOT1L plays a protective role in ultraviolet radiation (UVR)-induced melanoma development. Specifically, the DOT1L gene is located in a frequently deleted region and undergoes somatic mutation in human melanoma. Specific mutations functionally compromise DOT1L methyltransferase enzyme activity leading to reduced H3K79 methylation. Importantly, in the absence of DOT1L, UVR-induced DNA damage is inefficiently repaired, so that DOT1L loss promotes melanoma development in mice after exposure to UVR. Mechanistically, DOT1L facilitates DNA damage repair, with DOT1L-methylated H3K79 involvement in binding and recruiting XPC to the DNA damage site for nucleotide excision repair (NER). This study indicates that DOT1L plays a protective role in UVR-induced melanomagenesis.

Indexed as

AnimalsCarcinogenesisCells, CulturedDNA-Binding ProteinsDNA RepairHistone-Lysine N-MethyltransferaseHumansLoss of Function MutationMelanomaMethyltransferasesMiceMice, KnockoutProto-Oncogene Proteins B-rafUltraviolet RaysBRAF protein, humanDNA-Binding ProteinsDOT1L protein, humanDot1l protein, mouseHistone-Lysine N-MethyltransferaseMethyltransferasesProto-Oncogene Proteins B-rafXPC protein, human

Identifiers

PMID29343685
PMCPMC5772495
OpenAlexW2784108659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.